Aged
Aged, 80 and over
Androgen Antagonists
Antineoplastic Agents
Disease Progression
Double-Blind Method
Factor Analysis, Statistical
Humans
Imidazoles
Imidazolidines
Male
Middle Aged
Orchiectomy
Prognosis
Proportional Hazards Models
Prostatic Neoplasms
Survival Analysis
Treatment Outcome
